Stock tanks as Senseonics sets out to raise $105M through debt, public offerings
Senseonics Holdings Inc. is looking to raise more than $100 million through two offerings.
The Germantown company, with an implantable glucose monitor for patients with diabetes, has initiated an $80 million convertible note offering and another $25 million public offering of common stock, announced Tuesday.
For the convertible note, with an aggregate principal amount of 5.25%, a conve rsion rate and other terms will be determined at the point of the offering, according to public filings. That funding…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news